Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Assessing Renal Function Beyond Creatinine

Introduction to Alternative Methods

  • The American Journal of Transplantation and Kidney International recommend using cystatin C-based equations (CKD-EPI-CystC or CKD-EPI-Cr-CystC) as the primary alternative to creatinine for confirmatory testing, or measuring GFR directly using exogenous filtration markers like iohexol when accurate GFR determination will impact treatment decisions 1, 2, 3

Cystatin C-Based Assessment

  • Cystatin C provides superior renal function assessment compared to creatinine alone, particularly in populations where creatinine-based estimates are unreliable, according to the American Journal of Transplantation and American Journal of Kidney Diseases 1, 3
  • Cystatin C is a low molecular weight protein produced at a constant rate by all nucleated cells and is less influenced by muscle mass, gender, age, and nutritional status compared to creatinine, as stated in the American Journal of Transplantation 1
  • Among liver transplant recipients, cystatin C-based equations demonstrated superior performance (r²=0.78-0.83) compared to creatinine-based equations (r²=0.76-0.77) in estimating measured GFR, according to the American Journal of Transplantation 1
  • The combination of creatinine and cystatin C (CKD-EPI-Cr-CystC equation) provides the most precise estimate of measured GFR and improves risk stratification, as recommended by the American Journal of Kidney Diseases 3
  • KDIGO guidelines recommend using cystatin C for confirmatory testing in specific circumstances when eGFR based on creatinine is less accurate, particularly in patients with eGFR 45-59 mL/min/1.73 m² without albuminuria, as stated in the American Journal of Kidney Diseases 3

Direct Measurement of GFR Using Exogenous Markers

  • Direct GFR measurement represents the gold standard and should be used when accurate ascertainment will impact treatment decisions, according to the American Journal of Transplantation, Kidney International, and American Journal of Kidney Diseases 1, 2, 3
  • Iohexol is the preferred exogenous marker, with recent consensus standardization protocols published by the European Kidney Function Consortium in 2024, as stated in Kidney International 2
  • Iohexol is filtered without secretion or reabsorption by renal tubules and is exclusively eliminated by the kidneys unbound to proteins, according to the American Journal of Transplantation 1
  • The 2024 KDIGO guidelines specifically recommend harmonizing and standardizing mGFR protocols to improve accuracy and comparability, as stated in Kidney International 2

Alternative Creatinine-Based Approaches for Specific Situations

  • The Jelliffe equation for unstable kidney function calculates GFR based on volume of distribution and creatinine kinetics rather than steady-state parameters, as stated in Nature Reviews Nephrology 5
  • Standard eGFR equations (MDRD, CKD-EPI) cannot be used in ICU settings because they require serum creatinine to be in steady-state, according to Nature Reviews Nephrology 5

Common Pitfalls and Caveats

  • Never use serum creatinine concentration alone to assess kidney function, as recommended by Annals of Internal Medicine 6, 4
  • GFR must decline to approximately half the normal level before serum creatinine rises above the upper limit of normal, according to Annals of Internal Medicine 6, 4
  • 24-hour urine creatinine clearance does not provide more accurate estimates than prediction equations and is fraught with collection errors, as stated in Annals of Internal Medicine 6, 4